Delay and restricted access of new molecules in Turkey compared to the United States and European Union

por Şahin, Toros, Yeşil, Atakan, Topcu, Türker
Publicado 2013

Cost Effectiveness of Insulin Glargine versus Neutral Protamin Hagedorn Insulin in the Treatment of Type 2 Diabetes Patients in Turkey

por Satman, Ilhan, Bennett, Hayley, Yilmaz, Candeger, Imamoglu, Sazi, Ayvaz, Goksun, Comlekci, Abdurrahman, Ozkaya, Demet, Sahin, Toros
Publicado 2013

Modeling the future of HIV in Turkey: Cost-effectiveness analysis of improving testing and diagnosis

por Yaylali, Emine, Erdogan, Zikriye Melisa, Calisir, Fethi, Gokengin, Deniz, Korten, Volkan, Tabak, Fehmi, Tasova, Yesim, Unal, Serhat, Ozelgun, Berna, Ozcagli, Tahsin Gokcem, Sahin, Toros
Publicado 2023

Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey

por Oksuz, Ergun, Malhan, Simten, Gonen, Mustafa Sait, Kutlubay, Zekayi, Keskindemirci, Yilmaz, Jarrett, James, Sahin, Toros, Ozcagli, Gokcem, Bilgic, Ahmet, Bibilik, Merve Ozlem, Tabak, Fehmi
Publicado 2021